VOLITIONRX LTD·4

Feb 27, 4:30 PM ET

Innes Guy Archibald 4

Research Summary

AI-generated summary

Updated

VolitionRx (VNRX) Director Innes Archibald Receives 178,000 RSUs

What Happened Innes Guy Archibald, a director of VolitionRx Ltd (VNRX), was granted 178,000 restricted stock units (RSUs) on February 26, 2026. The award shows $0.00 cash consideration (i.e., RSUs issued in lieu of cash compensation). The RSUs will be earned in twelve roughly equal monthly installments beginning February 1, 2026, and any RSUs earned will remain subject to additional time-based vesting in a single installment on February 26, 2027. Upon vesting and settlement, each RSU converts into one share of common stock.

Key Details

  • Transaction type: Award/Grant (Form 4 code A) — 178,000 RSUs granted on 2026-02-26 at $0.00.
  • Filing: Reported on Form 4 filed 2026-02-27 (reporting period 2026-02-26) — appears timely.
  • Vesting schedule: Earned monthly (12 approx. equal installments starting 2/1/2026); additional single-date time-based vest on 2/26/2027; shares issued only upon vesting/settlement.
  • Shares owned after transaction: Not specified in the provided extract; filing notes other beneficial holdings (see footnotes).
  • Notable footnotes:
    • F1: RSUs granted in lieu of cash compensation; monthly earning plus final time-based vesting as described above.
    • F2: Some common shares are beneficially owned by The Innes Family Bare Trust 2023 (reporting person is Trustee).
    • F3: Some common shares are beneficially owned by The Dill Faulkes Educational Trust Limited (reporting person is director/trustee and disclaims beneficial ownership except to extent of pecuniary interest).

Context RSU grants are compensation, not open-market purchases or sales, and don’t necessarily signal insider buying or selling intent. These RSUs convert to common shares only upon the described earning and vesting schedule; there is no immediate transfer of tradable shares on the grant date.